Nav: Home

Researchers probing the beneficial secrets in dolphins' proteins

October 13, 2016

Why reinvent the wheel when nature has the answer?

That's what researcher Michael Janech, Ph.D. of the Medical University of South Carolina, has found to be true, drawing from the field of biomimicry where researchers look to nature for creative solutions to human problems.

In Janech's case, his natural inspiration is coming from dolphins who seem to have protective proteins that may contain clues to treatments for aging-associated diseases in humans. A recent study published in Nature's Scientific Reports September 26 issue found dolphin serum contains very high levels of an antioxidant protein.

Janech, director of MUSC's Nephrology Proteomics Laboratory, said he was surprised by the finding and excited about how this might be used in future studies to help humans. Dolphins survive dives that deprive vital organs of oxygen without causing damage and that for humans would be lethal. During dives that can last as long as 90 minutes, marine mammals restrict blood flow to their kidneys, liver, heart and lungs to shunt more oxygen to the brain.

When marine mammals resurface, oxygenated blood flow is restored to those organs without the organs suffering damage. In humans, though, the same phenomenon of hypoxia or being deprived of oxygen followed by re-oxygenation, such as experienced during heart attack, stroke and acute kidney injury, causes the release of free radicals thought to damage human organs. Janech, a kidney researcher and expert in proteomics, was curious what gives dolphins this advantage.

Proteomics is the study of all proteins that are encoded by the genes, he said. "We attempt to analyze all the proteins at once rather than individual proteins at one time in a cell or a tissue or an organism. It's just like genomics - when people are looking at 20,000 genes and seeing if they are high or low in certain disease states. We're doing the same thing with certain proteins."

That's no small feat.

"There are more than 100,000 protein variants, but each protein can be modified. We have more than a million different protein variants based on modifications."

Because the diversity of proteins is so large, researchers usually require mass spectrometers that perform at high resolution, allowing investigators to accurately determine the identity of proteins and other molecules of interest. This expertise came in handy in how the current study came about.

While Janech was working with the Marine Mammal Center in Sausalito, California, and the National Marine Mammal Foundation in San Diego, California, to identify biomarkers in sea lions affected by toxic algae blooms on the west coast, he learned that some of the managed dolphins in the U.S. Navy Marine Mammal program were living much longer than wild ones.

They were developing insulin resistance and fatty liver disease as they aged, a process consistent with the development of metabolic syndrome in people. This observation presented a rare opportunity.

"That's not a model that anybody sees in nature, because dolphins usually don't get this old in nature," said Janech.

Janech joined forces with Stephanie Venn-Watson, director of the National Marine Mammal Foundation's Translational Medicine Research Program in San Diego, and Randall Wells, director of the Chicago Zoological Society's Sarasota Dolphin Research Program in Florida. Venn-Watson is a veterinary expert of the Navy's managed dolphin populations, while Wells is an internationally respected expert of wild dolphin biology.

Together the group is attempting to determine the cause for insulin resistance in managed dolphins, and then use knowledge of human and dolphin similarities to find clues for treating the condition in both species. With funding provided by the Office of Naval Research, the Janech laboratory began to track adiponectin in the serum of the managed and wild bottlenose dolphin populations.

Levels of adiponectin, an insulin-sensitizing hormone, were predicted to be different in managed dolphins with metabolic syndrome in comparison with those in the wild. In order to verify the relevance of their work to human metabolic syndrome, they also performed simple proteomic analyses in human and dolphin serum samples.

Given that the major proteins in mammals are constant across species, they expected the highest concentration of proteins to be similar in both species. What they found when they looked just below the threshold, however, was surprising, he said.

Eleven proteins were at least 100-fold more prevalent in dolphin serum than in humans. At first, the group wrote this off as a difference in genetic ancestry: at some phylogenetic branch in the evolutionary tree of development, some mammals branched off and developed into two-toed ungulates and some went on to become primates.

Bottlenose dolphins are mammals descended from even-toed ungulates such as pigs, deer, and giraffes. To check that this was the case, they also mapped the serum proteome of the pig, and were again surprised. The 100-fold rank differences in 5 of the proteins, including vanin-1 and adiponectin, could not be explained away by simple phylogenetic differences.

While adiponectin is known to be higher in dolphins, as a way to control glucose storage during feeding, very high vanin-1 was a novel finding. Interestingly, excessively high vanin-1 levels were correlated with decreased liver function in the wild dolphins, which suggests they provide a protective effect in avoiding metabolic syndrome. But Janech, Venn-Watson, and Wells also noticed another potential need for vanin-1. The function of vanin-1 is to make vitamin B5 and in doing so it releases an antioxidant that has been shown to protect tissues from injury like that which occurs after the hypoxia and re-oxygenation of diving and resurfacing.

The question is if this could work also to help humans resist the hypoxia that causes acute kidney injury, which Janech has applied for a grant to the National Science Foundation to study. He and colleagues are gathering samples from a number of different diving and non-diving marine mammals, and land-bound mammals, and mapping their proteomes as well. They have continued their current collaboration, and also included graduate students from the College of Charleston's Grice Marine Laboratory and investigators from the National Institutes of Standards and Technology at Hollings Marine Laboratory to help with their measurements.

Janech said there's much to learn from the field of biomimicry, especially paired with proteomics.

"Proteins are the workhorses of the genes. It is how the gene provides function to the cell. The action of the cell happens through the proteins. That's why we want to study the proteins. These are your enzymes," he said.

"This is the first step. We wanted to ask what's different in an animal that can do something that would hurt a human, and they do this every single day. And can we take it back to human medicine?"
-end-


Medical University of South Carolina

Related Heart Attack Articles:

Where you live could determine risk of heart attack, stroke or dying of heart disease
People living in parts of Ontario with better access to preventive health care had lower rates of cardiac events compared to residents of regions with less access, found a new study published in CMAJ (Canadian Medical Association Journal).
Activated T-cells drive post-heart attack heart failure
Chronic inflammation after a heart attack can promote heart failure and death.
ICU care for COPD, heart failure and heart attack may not be better
Does a stay in the intensive care unit give patients a better chance of surviving a chronic obstructive pulmonary disease (COPD) or heart failure flare-up or even a heart attack, compared with care in another type of hospital unit?
Heart attack treatment might be in your face
Researchers at the University of Cincinnati have received $2.4 million in federal funding to pursue research on a novel cell therapy that would repair heart damage using modified cells taken from the patient's own facial muscle.
Tissue engineering advance reduces heart failure in model of heart attack
Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
Study shows functional effects of human stem cell delivery to heart muscle after heart attack
Researchers delivered human stem cells seeded in biological sutures to the damaged heart muscles of rats following induced acute myocardial infarction and assessed the effects on cardiac function one week later.
Younger heart attack survivors may face premature heart disease death
For patients age 50 and younger, the risk of premature death after a heart attack has dropped significantly, but their risk is still almost twice as high when compared to the general population, largely due to heart disease and other smoking-related diseases The risk of heart attack can be greatly reduced by quitting smoking, exercising and following a healthy diet.
After the heart attack: Injectable gels could prevent future heart failure (video)
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart.
Heart failure after first heart attack may increase cancer risk
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a study today in the Journal of the American College of Cardiology.
1 in 4 patients develop heart failure within 4 years of first heart attack
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr.

Related Heart Attack Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...